Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
Anna-Ursula HappelRavesh SinghNireshni MitchevKoleka MlisanaHeather B JaspanShaun L BarnabasJo-Ann S PassmorePublished in: BMC infectious diseases (2020)
This trial was registered on 17 October 2017 with the South African National Clinical Trial Register ( http://www.sanctr.gov.za/ ; BV-trial1; DOH-27-1117-5579 ).
Keyphrases
- phase iii
- phase ii
- clinical trial
- open label
- double blind
- south africa
- study protocol
- placebo controlled
- quality improvement
- hiv positive
- transcription factor
- lipopolysaccharide induced
- stem cells
- hepatitis c virus
- bone marrow
- hiv infected
- mesenchymal stem cells
- human immunodeficiency virus
- cell therapy
- bacillus subtilis
- lactic acid